Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Biomarkers to Predict Cancer Therapy-related Cardiotoxicity

Conditions: Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm
Interventions: Other: Non-Interventional Study
Sponsors: Mayo Clinic; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI)
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

April 9, 2024Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments